hotspot -WSS

hotspot

author：explore 2025-09-28 00:52:44 - browse：4317

Photography of the US department of health and human services in Silver Spring MD — Manuel Balce Ceneta/AP

An increasing number of medical device companies are submitting fabricated and unreliable data, the Food and Drug Administration noted Tuesday morning. The data comes from third-party labs hired by device firms to test the quality of their products.

Triple-check your data or we’ll reject your device, the FDA warned.

The goal of third-party testing is to ensure a device meets the FDA’s standards in a range of areas, including biocompatibility, sterility, and mechanical performance. The agency wrote that it has noticed an uptick in false data submissions in recent years, particularly from facilities based in China and India. In some cases, the facilities will send data copied from previous device submissions.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Food makers to regulators: Ultra

hotspot

WSS

Amazon expands telehealth clinic nationwide

Telehealth for opioid use disorder is lifesaving

FDA panel endorses Alnylam’s heart drug — after picking it apart

FDA panel endorses Alnylam’s heart drug — after picking it apart

Wildfire pollution widens asthma inequities on Long Island

How housing is health care on Long Island

knowledge

hotspot

knowledge

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

‘Oppenheimer’ and the risks of AI in health care

Virginia high school admissions case could be legal follow

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Malaria cases in Florida and Texas: Here’s what you need to know

National panel will explore requiring free Covid tests

Hollywood unions extend contract negotiations for actors

Food makers tried to stack nutrition panel with preferred experts

Sports medicine is finally prioritizing gender equality

IRA could hurt research into orphan drugs for rare diseases

hotspot

Popular nasal decongestant doesn't actually relieve congestion

How medical schools plan to diversify without affirmative action

White House touts steps to stem shortages of cancer treatments

New weight loss drugs vying to be the next Wegovy or Mounjaro

Diverse clinical trials: Why aren’t we there yet?

NIH launches clinical trials and new research office for long Covid

Wikipedia

hotspot

explore

focus